STIM1 and breast cancer: In contrast to STIM1 and Orai1, Orai3 has no N-glycosylation consensus motifs [23]; therefore, we have focused our studies in the functional role of STIM1 and Orai1 glycosylation in SOCE in the breast cancer cell types as compared to MCF10A breast epithelial cells.